Doxorubicin (Doxo) is a widely used chemotherapeutic drug for cancer, though it can have toxic effects on the heart. A recent animal study investigated whether the cardioregulatory protein chromogranin A (CgA) contributes to the regulation of the cardiotoxic and antitumor activities of Doxo.
